A groundbreaking milestone has been reached in the fight against malaria. Novartis announced today that its revolutionary therapy has received regulatory approval to combat malaria in newborns and infants, marking a major breakthrough in global health. This innovative pharmaceutical will now be available in countries where malaria is most prevalen